{
    "id": "correct_subsidiary_00045_0",
    "rank": 27,
    "data": {
        "url": "https://www.globenewswire.com/en/news-release/2023/06/07/2683844/0/en/Enhancing-Care-Expansion-of-Alpers-Disease-Treatment-Market-Size-On-its-Path-to-US-1-90-Billion-by-2030-at-a-4-57-of-CAGR.html",
        "read_more_link": "",
        "language": "en",
        "title": "Enhancing Care: Expansion of Alpers Disease Treatment Market Size On its Path to US$ 1.90 Billion by 2030, at a 4.57% of CAGR.",
        "top_image": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
        "meta_img": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
        "images": [
            "https://ml.globenewswire.com/media/MmI1ODZjMDEtMjk1NC00M2ZjLTk5MWMtNmY2OTZhYWQ3OGI3LTEwOTIzODY=/tiny/Zion-Market-Research.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Zion Market Research",
            "Alpers Disease Treatment Share",
            "Neurological Disorders",
            "Healthcare Industry",
            "Treatment Advancements",
            "Neurodegenerative Disorders"
        ],
        "tags": null,
        "authors": [
            "Zion Market Research"
        ],
        "publish_date": "2023-06-07T00:00:00",
        "summary": "",
        "meta_description": "Global Alpers Disease Treatment Market Size Poised To Reflect USD 1.90 billion Billion Mark by 2030. The key market players are listed in the report with...",
        "meta_lang": "en",
        "meta_favicon": "/Content/logo/favicon.ico",
        "meta_site_name": "GlobeNewswire News Room",
        "canonical_link": "https://www.globenewswire.com/en/news-release/2023/06/07/2683844/0/en/Enhancing-Care-Expansion-of-Alpers-Disease-Treatment-Market-Size-On-its-Path-to-US-1-90-Billion-by-2030-at-a-4-57-of-CAGR.html",
        "text": "Houston, TX, June 07, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Alpers Disease Treatment Market By Diagnosis (Molecular Genetic Testing, Laboratory Tests, Electroencephalography (EEG), And Others), By Treatment (Speech Therapy, Anticonvulsant Drugs, Occupational Therapy, Physical Therapy, And Others), By Demographic (Adolescent, Adult, Childhood, And Infancy), By Symptoms (Dementia, Headache, Seizures, Liver Dysfunction, Spasticity, Blindness, Cerebral Degeneration, And Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.\n\n“According to the latest research study, the demand of global Alpers Disease Treatment Market size & share in terms of revenue was valued at USD 1.33 billion in 2022 and it is expected to surpass around USD 1.90 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 4.57% during the forecast period 2023 to 2030.”\n\nWhat is Alpers Disease Treatment? How big is the Alpers Disease Treatment Industry?\n\nReport Overview:\n\nThe global Alpers disease treatment market size was worth around USD 1.33 billion in 2022 and is predicted to grow to around USD 1.90 billion by 2030 with a compound annual growth rate (CAGR) of roughly 4.57% between 2023 and 2030.\n\nThe Alpers disease treatment industry deals with the economic aspects of the development, production, distribution, and commercialization of therapies and treatments for Alpers disease. It is a progressive genetic disorder that generally manifests during early childhood and the symptoms of which worsen with age. However, people of all age groups are vulnerable to this disease but the chances are low as compared to children. Alpers disease is also known as Alpers-Huttenlocher syndrome and it impacts the central nervous system and liver. The treatment encompasses pharmaceutical companies, biotechnology firms, research institutions, healthcare providers, regulatory bodies, patient advocacy groups, and other stakeholders that work toward addressing the medical needs of the patients which includes drug and other supportive care.\n\nGet a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/alpers-disease-treatment-market\n\n(A free sample of this report is available upon request; please contact us for more information.)\n\nOur Free Sample Report Consists of the Following:\n\nIntroduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.\n\nThe COVID-19 Pandemic Outbreak Impact Analysis is included in the package\n\nAbout 207+ Pages Research Report (Including Recent Research)\n\nProvide detailed chapter-by-chapter guidance on Request\n\nUpdated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023\n\nIncludes Tables and figures have been updated\n\nThe most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis\n\nZion Market Research research methodology\n\n(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)\n\nGlobal Alpers Disease Treatment Market: Growth Factors\n\nThe global Alpers disease treatment market is projected to grow owing to increasing awareness about the disease. In recent times, the medical community along with regional government support and domestic or international healthcare organizations, has run multiple public awareness programs. With easy access to information aided by Internet technology, more people are aware of the disease and the medications available in the commercial market.\n\nFurthermore, the ongoing large-scale investments in developing global healthcare systems indirectly impact the industry; it is a growing concern in the medical care segment. This is strengthened by increasing collaboration between academic institutions, pharmaceutical companies, government agencies, and patient advocacy groups in a bid to improve the structure surrounding the treatment of the rare disease. Moreover, a rise in regulatory incentives for the treatment of rare conditions such as Alpers could create higher revenue in the market.\n\nThe global Alpers disease treatment industry is expected to come across growth restrictions owing to the lack of access to adequate healthcare in several countries. Since Alpers is a rare condition, the awareness rate is highly limited and this trend is especially observed in rural areas. Moreover, the high development cost of treatment methods further restricts market expansion as small research firms may not be able to undertake such large-scale research programs. The lack of standardized outcome measures along with the limited availability of treatment options is also major roadblocks prohibiting the market from attaining high growth.\n\nThe growing advancements in genetic research may provide excellent growth opportunities and the high cost of treatment could challenge market growth.\n\nDirectly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/alpers-disease-treatment-market\n\nReport Scope\n\nReport AttributeDetailsMarket Size in 2022USD 1.33 billionProjected Market Size in 2030USD 1.90 billionCAGR Growth Rate4.57% CAGRBase Year2022Forecast Years2023-2030Key Market PlayersRoche Holdings AG, Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Biogen Inc., Moderna, Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Regeneron Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., BioMarin Pharmaceutical Inc., Genzyme Corporation (a subsidiary of Sanofi), Horizon Therapeutics plc, Ultragenyx Pharmaceutical Inc., Amicus Therapeutics, Inc., CRISPR Therapeutics AG, Agios Pharmaceuticals, Inc., Mitobridge (a subsidiary of Astellas Pharma Inc.), Stealth BioTherapeutics Corp., NeuroVive Pharmaceutical AB, and Epizyme, Inc.Key SegmentBy Diagnosis, By Treatment, By Demographic, By Symptoms, and By RegionMajor Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East &, AfricaPurchase OptionsRequest customized purchase options to meet your research needs. Explore purchase options\n\nAlpers Disease Treatment Market: Segmentation Analysis\n\nThe global Alpers disease treatment market is segmented based on diagnosis, treatment, demographic, symptoms, and region.\n\nBased on diagnosis, the global market segments are molecular genetic testing, laboratory tests, electroencephalography (EEG), and others.\n\nBased on treatment, the global market divisions are speech therapy, anticonvulsant drugs, occupational therapy, physical therapy, and others. The Alpers disease treatment industry registered the highest growth in anticonvulsant drugs. Medicines such as valproic acid, levetiracetam, or others, are commonly prescribed to help control and manage seizures since they occur frequently during the condition. As of current times, there is no specific cure that is used to treat the patients, and multiple therapies in combination are used to provide patients with measures to improve their quality of life. For instance, Occupational therapy focuses on improving and maintaining functional skills necessary for daily living activities whereas supportive care deals with providing nutritional support, managing liver dysfunction, and monitoring and treating respiratory difficulties. Studies indicate that children diagnosed with Alpers do not survive above the age of 10 to 15 years.\n\nBased on demographic, the global market segments are adolescent, adult, childhood, and infancy.\n\nBased on symptoms, the Alpers disease treatment industry is divided into dementia, headache, seizures, liver dysfunction, spasticity, blindness, cerebral degeneration, and others. Patients may showcase different symptoms depending on several factors. However, the most common symptom that occurs in almost all patients is the onset of uncontrolled seizures. It is also considered as one of the earliest signs of Alpers. They may manifest as focal seizures, generalized tonic-clonic seizures (grand mal seizures), or other seizure types and as time progresses, it becomes difficult to control the intensity of these seizures. Some of the other common symptoms include neurological deterioration, developmental regression, cognitive decline, muscle weakness, liver dysfunction, spasticity, and optic atrophy. The NIH claims that less than 5000 people in the US are affected by the condition.\n\nThe global Alpers Disease Treatment market is segmented as follows:\n\nBy Diagnosis\n\nMolecular Genetic Testing\n\nLaboratory Tests\n\nElectroencephalography (EEG)\n\nOthers\n\nBy Treatment\n\nSpeech Therapy\n\nAnticonvulsant Drugs\n\nOccupational Therapy\n\nPhysical Therapy\n\nOthers\n\nBy Demographic\n\nAdolescent\n\nAdult\n\nChildhood\n\nInfancy\n\nBy Symptoms\n\nDementia\n\nHeadache\n\nSeizures\n\nLiver Dysfunction\n\nSpasticity\n\nBlindness\n\nCerebral Degeneration\n\nOthers\n\nBrowse the full “Alpers Disease Treatment Market By Diagnosis (Molecular Genetic Testing, Laboratory Tests, Electroencephalography (EEG), and Others), By Treatment (Speech Therapy, Anticonvulsant Drugs, Occupational Therapy, Physical Therapy, and Others), By Demographic (Adolescent, Adult, Childhood, and Infancy), By Symptoms (Dementia, Headache, Seizures, Liver Dysfunction, Spasticity, Blindness, Cerebral Degeneration, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030\"- Report at https://www.zionmarketresearch.com/report/alpers-disease-treatment-market\n\nCompetitive Landscape\n\nSome of the main competitors dominating the global Alpers Disease Treatment market include -\n\nRoche Holdings AG\n\nPfizer Inc.\n\nNovartis International AG\n\nSanofi S.A.\n\nMerck & Co.Inc.\n\nBiogen Inc.\n\nModerna Inc.\n\nVertex Pharmaceuticals Incorporated\n\nAlexion Pharmaceuticals Inc.\n\nTakeda Pharmaceutical Company Limited\n\nAbbVie Inc.\n\nRegeneron Pharmaceuticals Inc.\n\nIonis Pharmaceuticals Inc.\n\nSarepta Therapeutics Inc.\n\nBioMarin Pharmaceutical Inc.\n\nGenzyme Corporation (a subsidiary of Sanofi)\n\nHorizon Therapeutics plc\n\nUltragenyx Pharmaceutical Inc.\n\nAmicus Therapeutics Inc.\n\nCRISPR Therapeutics AG\n\nAgios Pharmaceuticals Inc.\n\nMitobridge (a subsidiary of Astellas Pharma Inc.)\n\nStealth BioTherapeutics Corp.\n\nNeuroVive Pharmaceutical AB\n\nEpizyme Inc.\n\nKey Insights from Primary Research:\n\nAccording to the analysis shared by our research forecaster, the Alpers Disease Treatment market is likely to expand at a CAGR of around 4.57% during the forecast period (2023-2030).\n\nIn terms of revenue, the Alpers Disease Treatment market size was valued at around US$ 1.33 billion in 2022 and is projected to reach US$ 1.90 billion by 2030.\n\nThe Alpers disease treatment market is projected to grow at a significant rate due to the growing research and development.\n\nBased on diagnosis segmentation, molecular genetic testing was predicted to show maximum market share in the year 2022.\n\nBased on demographic segmentation, childhood was the leading demographic in 2022.\n\nOn the basis of region, North America was the leading revenue generator in 2022.\n\nHave Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/alpers-disease-treatment-market\n\nKey questions answered in this report:\n\nWhat is the market size and growth rate forecast for Alpers Disease Treatment industry?\n\nWhat are the main driving factors propelling the Alpers Disease Treatment Market forward?\n\nWhat are the leading companies in the Alpers Disease Treatment Industry?\n\nWhat segments does the Alpers Disease Treatment Market cover?\n\nHow can I receive a free copy of the Alpers Disease Treatment Market sample report and company profiles?\n\nKey Offerings:\n\nMarket Size & Forecast by Revenue | 2023−2030\n\nMarket Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities\n\nMarket Segmentation – A detailed analysis By Diagnosis, By Treatment, By Demographic, By Symptoms, and By Region\n\nCompetitive Landscape – Top Key Vendors and Other Prominent Vendors\n\nRequest for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7225\n\n(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)\n\nRegional Analysis:\n\nThe global Alpers disease treatment market is expected to be dominated by North America during the forecast period with the US leading with the highest regional market share. This can be attributed to the increasing number of research programs on gene therapy and rare genetic conditions. Moreover, high disposable income, the presence of adequate medical reimbursement policies, and access to advanced medical diagnostic tools aided by a high awareness rate are crucial to growth in this region.\n\nEurope is projected to become the second leading market in the global industry due to the excellent healthcare infrastructure of countries such as the United Kingdom, Germany, and France. European nations have a strong and medically-inclined regulatory framework that supports studies on rare diseases and orphan drug development which could act in favor of the European growth trajectory.\n\nBy Region\n\nNorth America\n\nU.S.\n\nCanada\n\nRest of North America\n\nEurope\n\nFrance\n\nUK\n\nSpain\n\nGermany\n\nItaly\n\nRest of Europe\n\nAsia Pacific\n\nChina\n\nJapan\n\nIndia\n\nSouth Korea\n\nRest of Asia Pacific\n\nThe Middle East & Africa\n\nSaudi Arabia\n\nSouth Africa\n\nRest of the Middle East & Africa\n\nLatin America\n\nBrazil\n\nArgentina\n\nRest of Latin America\n\nRecent Developments\n\nIn March 2023, the National Institute for Health and Care Research (NIHR) announced the launch of several initiatives with a total funding of £800 million for its biomedical Research Centers (BRC) that will study a wide range of rare medical conditions\n\nIn January 2023, Pfrizer stepped back from its early-stage rare disease research & development initiative while maintaining ties with certain programs with the aid of strategic investments\n\nTo know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/alpers-disease-treatment-market\n\nFREQUENTLY ASKED QUESTIONS\n\nWhat is Alpers disease treatment?\n\nWhich key factors will influence Alpers disease treatment market growth over 2023-2030?\n\nWhat will be the value of the Alpers disease treatment market during 2023-2030?\n\nWhat will be the CAGR value of the Alpers disease treatment market during 2023-2030?\n\nWhich region will contribute notably towards the Alpers disease treatment market value?\n\nWhich are the major players leveraging the Alpers disease treatment market growth?\n\nBrowse Other Related Research Reports from Zion Market Research:\n\nU.S. Healthcare Transportation Services Market By Type (Medical Transportation, Incubator Transport, Mobile Treatment Facilities, Patient Transport, And Non-Medical Transportation). By End Use (Hospitals, Medical Centers, Nursing Care Facilities, And Airport Shuttle), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/the-us-healthcare-transportation-services-market\n\nConnected Healthcare Market By Type (MHealth Services, MHealth Devices, And E-Prescription), By Function (Remote Patient Monitoring, Clinical Monitoring, Telemedicine, And Others), By Application (Diagnosis & Treatment, Monitoring Applications, Wellness & Prevention, Healthcare Management, And Others), By End User (Hospitals & Clinics And Home Monitoring), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/connected-healthcare-market\n\nAnimal Healthcare Market By Animal Type Outlook (Production Animal, Companion Animal), By Product Outlook (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others), By Distribution Channel Outlook (Retail, E-Commerce, Veterinary Hospitals & Clinics), By End-Use Outlook (Reference Laboratories, Point-Of-Care Testing/In-House Testing, Veterinary Hospitals & Clinics), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/animal-healthcare-market\n\nHealthcare Facilities Management Market- By End-User (Hospitals & Clinics, Ambulatory Service Centers, And Long-Term Healthcare Facilities), By Services (Hard Services And Soft Services), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2028: https://www.zionmarketresearch.com/report/healthcare-facilities-management-market\n\nHealthcare Regulatory Affairs Outsourcing Market- By Services (Regulatory Writing & Publishing, Clinical Trial Applications & Services Registrations, Regulatory Consulting & Legal Representation, And Regulatory Submissions), By End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, And Food & Beverage Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2028: https://www.zionmarketresearch.com/report/healthcare-regulatory-affairs-outsourcing-market\n\nHealthcare Contract Development And Manufacturing Organization Market- By Services (Contract Manufacturing And Contract Development): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021–2028: https://www.zionmarketresearch.com/report/healthcare-contract-development-manufacturing-organization-market\n\nRFID In Healthcare Market By Product (Systems & Software, Tags), By Application (Asset Tracking, Patient Tracking, Pharmaceutical Tracking, Blood Tracking, Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028: https://www.zionmarketresearch.com/report/rfid-in-healthcare-market\n\nHealthcare IT Integration Market By Product (Medical Device Integration, Interface Engine, And Media Integration), By Service (Education, Support And Integration), By End Users (Diagnostic Imaging Centers, Laboratories, And Hospitals): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2028: https://www.zionmarketresearch.com/report/healthcare-it-integration-market\n\nHealthcare Predictive Analytics Market By Application(Clinical Data Analytics, Financial Data Analytics, Research Data Analytics, Operations Management And Others), By Product (Hardware And Software & Services), By Modes Of Delivery (On Premise And Cloud Based), By End User(Healthcare Provider, Pharmaceutical Industry And Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028: https://www.zionmarketresearch.com/report/healthcare-predictive-analytics-market\n\nHealthcare Video Conferencing Solutions Market- By Deployment Mode (On-Premise And Cloud-Based), By Component (Hardware, Software, And Services), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2028: https://www.zionmarketresearch.com/report/healthcare-video-conferencing-solutions-market\n\nHealthcare E-Commerce Market - By Type (Drug And Medical Devices), By Application (Telemedicine, Medical Consultation, And Caregiving Services), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2028: https://www.zionmarketresearch.com/report/healthcare-e-commerce-market\n\nHealthcare M2M Market By Technology Segmentation (Wired, Wireless And Cellular Technology), By Industry Vertical (Healthcare, Utilities, Automotive & Transportation, Retail, Consumer Electronic And Security & Surveillance), By Application (Patient Well-Being, Medical Facilities, Sports & Fitness, And Others): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028: https://www.zionmarketresearch.com/report/healthcare-m2m-market\n\nHealthcare Information System Market By Delivery Mode (On-Premises Installation, Cloud Based Technology, And Web-Based Technology), Component (Software, Hardware, And Services), By Application (Pharmacy Information System, Laboratory Information System, And Hospital Information System): Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028: https://www.zionmarketresearch.com/report/healthcare-information-system-market\n\n4D Printing in Healthcare Market: by Component (Equipment, 3D Printers, 3D Bioprinters, Programmable Materials, Shape-memory Materials, Hydrogels, Living cells, and Software & Services), Technology (FDM, PolyJet, Stereolithography, and SLS), Application (Medical Models, Surgical Guides, Patient-specific Implants) & end-user (Hospitals & Clinics, Dental Laboratories and Other End-Users) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025: https://www.zionmarketresearch.com/report/4d-printing-in-healthcare-market\n\nCyber Security in Healthcare Market by Deployment Type (On-Premises and Cloud-Based), by Security Type (Application Security, Cloud Security, Content Security, Endpoint Security, Network Security, and Wireless Security), and by End-User (Pharmaceutical & Chemical Manufactures, Medical Device Companies, Health Insurance Companies, Hospitals & Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2026: https://www.zionmarketresearch.com/report/cyber-security-healthcare-market\n\nAbout Zion Market Research:\n\nZion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.\n\nOur client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.\n\nFollow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/\n\nFollow Us on Twitter: https://twitter.com/zion_research\n\nFollow Us on Facebook: https://www.facebook.com/zionmarketresearch\n\nFollow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/\n\nFollow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs\n\nContact Us:\n\nRushikesh Dorge\n\nUSA: +1 347 690-0211\n\nUnited Kingdom: +44 2032 894158\n\nJapan: +81 50 5806 9039\n\nIndia: +91 7768 006 007\n\nWeb: https://www.zionmarketresearch.com/\n\nBlog: https://zmrblog.com/\n\nBlog: https://www.lmgforhealth.org/\n\nStill, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?\n\nEmail Directly Here with Detail Information: sales@zionmarketresearch.com"
    }
}